Introduction to Oncology and Chemotherapy

Healthcare Education Services / CHI
Last Modified: July 13, 2008

Conference Dates: October 29-30, 2008
Conference Location: San Diego, CA

Sponsoring Group: Healthcare Education Services / CHI

Conference Web Page URL: http://www.healthtech.com/Conferences_Overview.aspx?id=76030

Topics Covered:

  • Cancer: Terminology and classification
  • Introduction to anti-cancer drugs
  • Side effects of chemotherapy and radiotherapy
  • New developments in cancer therapy Introduction to: Breast, lung, upper
  • GI, colorectal, ovarian, prostate and skin cancers
  • Clinical trial issues in oncology

Conference Objectives: Delegates attending this course will benefit from an introductory overview of the terminology and treatment.

Who Should Attend: Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.

Conference Agenda: Schedule: October 29: 8:30 am – 5:30 pm October 30: 8:00 am – 4:00 pm

Registration Information: Venue & Administrative Details: The registration fee at our VIP Discount Rate is $3,105 USD (regular rate $3,450 USD). This includes lunch and refreshments throughout the day. Accommodation costs are not included. Delegates can register on-line or by completing the booking form and returning it together with the appropriate payment to Cambridge Healthtech Institute. Please retain a copy of the booking form for your records. Details of the venue will be supplied on registration.

Conference Fees: $3,105

Continuing Education: No

Related News

Therapy-Related Leukemia Risk Varied From 1975 to 2008

Feb 19, 2013

Risk after chemotherapy varies depending on initial cancer and treatment practices


Preterm Birth Risk Down With Introduction of Smoking Bans

Feb 18, 2013

Reductions in 2007 and 2010 after implementation of smoking restriction policies in Belgium


Gene Expression Profile Testing Increasing in Breast Cancer

May 18, 2012

Linked with decrease in chemotherapy in women with hormone receptor-positive breast cancer